Investors

Founded in 2000, Oryzon is one of the pioneers in the Spanish Biotech field. An Equity history with several successful funding rounds, a highly experienced Executive Management and more than 8 years of track record of recurrent revenues, national and international alliances and a patent portfolio with more than 50 International Patent applications makes of Oryzon a good opportunity for investors interested in the field.